18 May 2013
Keywords: aeterna, zentaris, completes, sale, royalties, merck, serono
Article | 08 November 2008
Canadian drugmaker AEterna Zentaris has completed the sale of its rights to royalties on future sales of in vitro fertilization ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
10 November 2008
17 May 2013
© 2013 thepharmaletter.com